With this in mind, we have designed a platform, named Trillium, which enables radiotherapeutics to bind to albumin, thereby enhancing circulation throughout the body and improving tumor delivery. By ...

Tb-161 offers a potential advantage over Lu-177 due to its emission of Auger electrons, which are highly effective in ...

(Nasdaq: PSTV) (“Plus” or the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system ...

This partnership represents a step forward in addressing the limited access to Gd-160, a barrier that Isotopia says has long restricted the advancement of Tb-161-based treatments into clinical trials.

Attacking Cancer Targets with Radiotherapeutics Attacking Cancer Targets with Radiotherapeutics John Babich from Ratio Therapeutics explains how radiopharmaceuticals can be designed to better treat ...

Jack and John tell Jonah about the emerging area of targeted radiotherapeutics and how their company is combining that technology with mathematical modelling to optimise this exciting new area of ...